The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...
Results from pritelivir Phase 2 study demonstrate a favorable safety profile and a numerically higher lesion healing rate vs. foscarnetPritelivir ...
The US National Security Agency hacked China’s National Time Service Center over several years, the Chinese counter-espionage agency has claimed. China has accused the US National Security Agency (NSA ...
A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...
Learn how to safely get your COVID and flu shots at the same time, which vaccine options to consider, and the best timing for ...
An analysis of patient records suggests that mRNA covid-19 vaccines boost the immune response to cancerous tumours when given ...
Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...
Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...
Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...
A multi-institutional team led by University of Washington scientists have engineered a new vaccine platform combining mRNA ...
A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new ...
RNA vaccines are quick and easy to make, while virus-like nanoparticles produce a stronger immune response. Now, the two ...